CIK 0001535955 · Non-accelerated filer<br>Smaller reporting company
Lipocine Inc.
Sign in to watch- Ticker
- LPCN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990370688
- Phone
- 801 994 7383
- Business address
- 675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, United States, 84108
- Former names
- MARATHON BAR CORP
- Open-market buys, last 90 days
- $161,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$161,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-04 | Higuchi John W. Director | Grant or award · Common Stock (Right to Buy) | +1,764 | $3.20 | $6K | 11,526 |
| 2025-06-04 | Fink Jeffrey Arvin Director | Grant or award · Common Stock (Right to Buy) | +1,764 | $3.20 | $6K | 11,526 |
| 2025-01-02 | Patel Mahesh V. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +16,371 | $4.86 | $80K | 149,039 |
| 2024-12-23 | Patel Mahesh V. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +10,320 | $4.80 | $50K | 132,688 |
| 2024-12-23 | Patel Mahesh V. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +26,691 | $4.80 | $128K | 149,039 |
| 2024-12-23 | Fogarty Krista Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +5,943 | $4.80 | $29K | 19,460 |
| 2024-06-05 | Papapetropoulos Spyros Director | Grant or award · Stock Option (Right to Buy) | +1,764 | $7.05 | $12K | 5,410 |
| 2024-06-05 | Ono Richard Dana Director | Grant or award · Common Stock (Right to Buy) | +1,764 | $7.05 | $12K | 10,938 |
| 2024-06-05 | Jene Jill M. Director | Grant or award · Stock Option (Right to Buy) | +1,764 | $7.05 | $12K | 5,410 |
| 2024-06-05 | Higuchi John W. Director | Grant or award · Common Stock (Right to Buy) | +1,764 | $7.05 | $12K | 10,938 |
| 2024-06-05 | Fink Jeffrey Arvin Director | Grant or award · Common Stock (Right to Buy) | +1,764 | $7.05 | $12K | 10,938 |
| 2024-03-08 | Patel Mahesh V. CEO and President | Grant or award | +4,893 | 112,311 | ||
| 2024-03-08 | Fogarty Krista Principal Accounting Officer | Grant or award | +991 | 1,727 | ||
| 2023-05-25 | Patel Mahesh V. CEO and President | Purchase | +8,706 | $5.03 | $44K | 107,418 |
| 2023-05-10 | Papapetropoulos Spyros Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $0.27 | $8K | 62,000 |
| 2023-05-10 | Higuchi John W. Director | Grant or award · Common Stock (Right to Buy) | +30,000 | $0.27 | $8K | 156,000 |
| 2023-05-10 | Ono Richard Dana Director | Grant or award · Common Stock (Right to Buy) | +30,000 | $0.27 | $8K | 166,000 |
| 2023-05-10 | Jene Jill M. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $0.27 | $8K | 62,000 |
| 2023-05-10 | Fink Jeffrey Arvin Director | Grant or award · Common Stock (Right to Buy) | +30,000 | $0.27 | $8K | 166,000 |
| 2023-03-24 | Patel Mahesh V. CEO and President | Purchase | +150,000 | $0.32 | $48K | 1,678,090 |
Page 2 of 8 · 144 trades